Since anti-hypertensive therapy with hydralazine prevented both angiotensin II-induced brain inflammation and cognitive impairment, our data are consistent with the concept that hypertension-induced brain inflammation leads to cognitive impairment. The gene discussed is AGT; the disease is Cognitive impairment.